(Q37461656)

20 August 2017

1 reference

title

Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues (English)

1 reference

20 August 2017

1 reference

R P J Schroeder

1

1 reference

20 August 2017

W M van Weerden

2

1 reference

20 August 2017

C Bangma

3

1 reference

20 August 2017

E P Krenning

4

1 reference

20 August 2017

M de Jong

5

1 reference

20 August 2017

publication date

3 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

48

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

200-204

1 reference

Small-animal preclinical nuclear medicine instrumentation and methodology.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Oncological molecular imaging: nuclear medicine techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

7 January 2021

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Screening and prostate-cancer mortality in a randomized European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Nuclear medicine studies of the prostate, testes, and bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Indium-111-capromab pendetide scans: an important test relevant to clinical decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

New treatment approaches for prostate cancer based on peptide analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Pharmacology and neurochemistry of bombesin-like peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

Alytesin and bombesin, two peptide analogs from amphibian skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.04.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2009.04.002

1 reference

20 August 2017

1 reference